← FDA Drug Approvals (Drugs@FDA)
RUFINAMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2022-11-07
Drug application
- FDA Application #
ANDA214009- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RUFINAMIDE
- Generic name
- Rufinamide
- Active ingredients
- RUFINAMIDE
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- CHARTWELL RX
- First approval
- 2022-11-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown